tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

GRCE Stock Latest News

Grace Therapeutics announces presentation of Phase 3 STRIVE-ON safety trial
The FlyGrace Therapeutics announces presentation of Phase 3 STRIVE-ON safety trial
7d ago
GRCE
Grace Therapeutics Secures New Patent for GTx-104
PremiumCompany Announcements
Grace Therapeutics Secures New Patent for GTx-104
11d ago
8K
GRCE
Grace granted sixth U.S. patent covering I.V. dosing regimen for GTx-104
PremiumThe Fly
Grace granted sixth U.S. patent covering I.V. dosing regimen for GTx-104
11d ago
GRCE
Grace Therapeutics Holds Annual Stockholders Meeting
PremiumCompany Announcements
Grace Therapeutics Holds Annual Stockholders Meeting
16d ago
8K
GRCE
FDA Accepts Grace Therapeutics’ NDA for GTx-104
PremiumCompany Announcements
FDA Accepts Grace Therapeutics’ NDA for GTx-104
1M ago
8K
GRCE
Grace Therapeutics announces U.S. FDA accepted NDA for GTx-104 for review
PremiumThe FlyGrace Therapeutics announces U.S. FDA accepted NDA for GTx-104 for review
1M ago
GRCE
Grace Therapeutics Reports Q2 2025 Earnings and Strategic Focus
Premium
Company Announcements
Grace Therapeutics Reports Q2 2025 Earnings and Strategic Focus
2M ago
GRCE
Grace Therapeutics reports Q1 EPS (21c) vs (24c) last year
Premium
The Fly
Grace Therapeutics reports Q1 EPS (21c) vs (24c) last year
2M ago
GRCE
Grace Therapeutics management to meet virtually with Craig-Hallum
PremiumThe Fly
Grace Therapeutics management to meet virtually with Craig-Hallum
2M ago
GRCE
Grace Therapeutics Submits New Drug Application to FDA
PremiumCompany Announcements
Grace Therapeutics Submits New Drug Application to FDA
3M ago
8K
GRCE
Grace Therapeutics announces submission to U.S. FDA of NDA for GTx-104
PremiumThe Fly
Grace Therapeutics announces submission to U.S. FDA of NDA for GTx-104
3M ago
GRCE
Grace Therapeutics Reports Promising Drug Development Progress
PremiumCompany Announcements
Grace Therapeutics Reports Promising Drug Development Progress
3M ago
GRCE
U.S. strikes Iran nuclear sites, Novo terminates Hims & Hers deal: Morning Buzz
PremiumThe FlyU.S. strikes Iran nuclear sites, Novo terminates Hims & Hers deal: Morning Buzz
3M ago
BK
AMD
Grace Therapeutics reports FY25 EPS (79c), consensus ($1.66)
Premium
The Fly
Grace Therapeutics reports FY25 EPS (79c), consensus ($1.66)
3M ago
GRCE
Apple downgraded, Reddit upgraded: Wall Street’s top analyst calls
Premium
The Fly
Apple downgraded, Reddit upgraded: Wall Street’s top analyst calls
5M ago
AZO
BDX
Grace Therapeutics initiated with a Buy at TD Cowen
PremiumThe Fly
Grace Therapeutics initiated with a Buy at TD Cowen
5M ago
GRCE
Grace announces alignment with FDA on planned NDA submission for GTx-104
PremiumThe Fly
Grace announces alignment with FDA on planned NDA submission for GTx-104
6M ago
GRCE
Grace Therapeutics Reports Q3 Progress and Financial Results
PremiumCompany Announcements
Grace Therapeutics Reports Q3 Progress and Financial Results
7M ago
GRCE
Grace Therapeutics Files Form S-3 for Flexible Securities Offering
PremiumCompany Announcements
Grace Therapeutics Files Form S-3 for Flexible Securities Offering
7M ago
GRCE
Grace Therapeutics files to sell 8.84M shares of common stock for holders
PremiumThe FlyGrace Therapeutics files to sell 8.84M shares of common stock for holders
7M ago
GRCE
Promising Potential of Grace Therapeutics’ GTX-104 Drives Buy Rating
Premium
Ratings
Promising Potential of Grace Therapeutics’ GTX-104 Drives Buy Rating
7M ago
GRCE
Grace Therapeutics reports Q3 EPS (36c), consensus (46c)
Premium
The Fly
Grace Therapeutics reports Q3 EPS (36c), consensus (46c)
8M ago
GRCE

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >